Hemoglobin Point-of-Care Testing

Correlation between Standard Clinical Chemistry and Point of Care Testing Analyzers on Hemoglobin A1C Determination

Point-of-Care Hemoglobin A1c Testing: An Evidence-Based Analysis.

BACKGROUND The increasing prevalence of diabetes in Ontario means that there will be growing demand for hemoglobin A1c (HbA1c) testing to monitor glycemic control for the management of this chronic disease. Testing HbA1c where patients receive their diabetes care may improve system efficiency if the results from point-of-care HbA1c testing are comparable to those from laboratory HbA1c measureme...

correlation between standard clinical chemistry and point of care testing analyzers on hemoglobin a1c determination

Accuracy of noninvasive hemoglobin and invasive point-of-care hemoglobin testing compared with a laboratory analyzer

INTRODUCTION Hemoglobin concentration is assessed to detect anemia and its associated morbidities. Hemoglobin is usually determined from venous or capillary blood samples run on a laboratory analyzer. However, this method requires a needle stick and results can be delayed. It also exposes caregivers to risks associated with needle sticks and blood exposure. Noninvasive hemoglobin determination ...

Comparison of costs of hemoglobin A1c determination by point-of-care testing (POCT) and standard hemoglobin A1c analyzer

OBJECTIVE The use of the levels of hemoglobin A1c for the monitoring of glycemic control in patients with diabetes mellitus (DM) is an accepted method of clinical usefulness. A study was performed to assess the relative costs of hemoglobin A1c determination by diagnostic testing at or near the site of patient care (point-of-care testing, POCT) and using the standard hemoglobin A1c analyzer. MET...